C200 schreef op 1 maart 2019 07:37:
Kiadis Pharma to present at upcoming investor conferences in
March 2019
Amsterdam, The Netherlands, March 1, 2019 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS), a clinical stage biopharmaceutical company, today announces that it is scheduled to present at the following investor conferences in March 2019.
Cowen Healthcare Conference
March 11-13, 2019, Marriott Copley Place, Boston, MA, USA
Kiadis will be presenting on March 12th at 10:00 EST.
BioCapital Europe
March 14, 2019, Sofitel Legend Amsterdam The Grand, Amsterdam, Netherlands
Kiadis will be presenting at 17:00 CET.
Oppenheimer 29th Annual Healthcare Conference
March 19-20, 2019, The Westin New York Grand Central, New York, NY, USA
Kiadis will be presenting on March 19, 2019 at 14:45 EST.
KBC Securities Healthcare Conference
March 27, 2019, Convene Grand Central, New York, NY, USA
Kiadis will be participating and hosting meetings with investors; there are no company presentations at this conference.
Kiadis Contacts:
Kiadis Pharma:
Amy Sullivan, SVP, Corporate Affairs
Tel. +1 508 479 3480
a.sullivan@kiadis.comOptimum Strategic Communications:
Mary Clark, Supriya Mathur, Hollie Vile
Tel: +44 203 950 9144
David Brilleslijper (Amsterdam)
Tel: +31 610 942 514
kiadis@optimumcomms.com